Clinical Trial Update: Ketamine for Depression and Suicide Risk [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ketamine for treatment of depression and suicidality; the study has completed and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Suicidal Ideation

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Mayo Clinic | Conditions: Depression, Suicide | Phase 2 | Status: COMPLETED | Results posted: 2017-08-11